CD47 and breast cancer: CD47 overexpression has been reported in various human malignancies including non-Hodgkin lymphoma, stomach cancer, oral squamous cell carcinoma, lung cancer, breast cancer, and hepatocellular carcinoma and has been correlated with adverse prognosis [28,29,30,31,32,33].